Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,677-8,688 of 10,592
Behavioral study icon
CompletedNCT00998153

Risk Reduction for Drug Use and Sexual Revictimization

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralFrom 12 Years to 17 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
PTSD
Drug study icon
CompletedNCT00177164

Risperdal Consta for Bipolarity

This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.

In United States
BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity
Drug study icon
CompletedNCT00176202

Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

In United States
BipolarityDrugFrom 10 Years to 20 Years
Countries
United States
Sponsor
University of Illinois at Chicago
Condition
Bipolarity
Drug study icon
CompletedNCT00167154

Risperidone and Suicide prevention in Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Depression, SuicidalityDrugFrom 19 Years to 60 Years
Countries
United States
Sponsor
University of Alabama at Birmingham
Condition
Depression, Suicidality
Drug study icon
CompletedNCT00215241

Risperidone Augmentation for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Duke University
Condition
PTSD
Drug study icon
CompletedNCT00289861

Risperidone Augmentation in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.